ORMP (Oramed Pharmaceuticals) Kacepetan wutah bathi saben saham ing taun lumaku
The volatility of annual earnings per share demonstrates the ecological vector of Oramed Pharmaceuticals (ORMP), which eliminates the use of needles and syringes. Business stability relies on the patented POD system that protects proteins in the gastrointestinal tract. Today, 245.50 expresses the current value of the metric, highlighting the company's potential for pricing power driven by high demand among diabetics for innovative capsules over injections.
Rincian metrik keuangan lan pasar oramed.com (ORMP)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Oramed Pharmaceuticals|ORMP - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Oramed Pharmaceuticals Inc.|ORMP - Utang perusahaan|Utang marang nilai buku ORMP|ORMP - Utang jangka dawa perusahaan|Utang jangka cendhak Oramed Pharmaceuticals|Rasio likuiditas darurat oramed.com
- indikator pendapatan resik lan kelipatan nilai:
ORMP - Penghasilan resik|Penghasilan resik sing dikarepake Oramed Pharmaceuticals|ORMP - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Oramed Pharmaceuticals Inc.|ORMP - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan ORMP|ORMP - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Oramed Pharmaceuticals|ORMP - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan oramed.com|ORMP - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Oramed Pharmaceuticals
- data pendapatan lan penerimaan dodolan:
Analisis dhasar perusahaan:ORMP, Oramed Pharma
This indicator mathematically captures the dynamics of net profit per share, reflecting the efficiency of cash flow management. The metric measures the percentage deviation of current EPS from the previous year's value, uncovering hidden costs. For Oramed Pharmaceuticals (ORMP), this calculation is critical when scaling the development of oral insulin. By analyzing the annual growth of net profit per share in percentage terms on GURU.Markets, an investor assesses the financial stability of this biotech innovator.
Pesaing langsung
Haleon PLC - Tambahing bathi saben saham ing taun lumaku|KVUE (Kenvue Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Verona Pharma Inc. VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Amneal AMRX|Perrigo Company PLC (PRGO) - Kacepetan wutah bathi saben saham ing taun lumaku|ALVO - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku LQDA (Liquidia Inc.)|GLPG: Wutah bathi ing taun lumaku|anipharmaceuticals.com (ANIP) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku MannKind|Wutah bathi resik saben saham ing taun iki Amphastar Pharmaceuticals Inc (AMPH)|Wutah bathi ing taun lumaku PCRX|SPRY - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku TBPH (Theravance Biopharma)|AQST: Wutah bathi saben saham ing taun iki|SCPH: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku TECX (Tectonic Therapeutic, Inc.)|Tonix Pharmaceuticals Inc. (TNXP) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku SXTC (China SXT Pharmaceuticals, Inc.)|EPRX (Eupraxia Pharmaceuticals, Inc.) - Wutah bathi ing taun lumaku|BHST: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku EXOZ|Wutah bathi ing taun lumaku enterabio.com (ENTX)|Wutah bathi saben saham ing taun lumaku MindWalk HYFT|Tambahing bathi saben saham ing taun lumaku ABVC|CPIX - Wutah bathi saben saham ing taun lumaku|quantumbiopharma.com (QNTM) - Wutah bathi resik saben saham ing taun iki|FGEN: Wutah bathi ing taun lumaku|Telomir Pharmaceuticals Inc (TELO) - Wutah bathi ing taun lumaku|RANI (Rani Therapeutics Holdings) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Synergy CHC Corporation (SNYR)|Wutah bathi ing taun lumaku RLYB|LEXX - Kacepetan wutah bathi saben saham ing taun lumaku|Pulmatrix - Wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku Pheton Holdings Limited PTHL|APM: Wutah bathi resik saben saham ing taun iki|Lyra Therapeutics Inc - Wutah bathi resik saben siji saham kanggo taun lumaku|IBO: Wutah bathi ing taun lumaku|TNFA - Prakiraan wutah bathi resik saben saham ing taun iki|YCBD (cbdMD Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki PainReform Ltd (PRFX)|Wutah bathi ing taun lumaku CYTO|Wutah bathi ing taun lumaku Lipella Pharma (LIPO)|Wutah bathi saben saham ing taun lumaku OptiNose, Inc. OPTN|pieris.com - Wutah bathi saben saham ing taun lumaku|PROC - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Petros Pharmaceuticals Inc PTPI|Qilian International Holding Group Limited (QLI) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku ACELYRIN Inc. (SLRN)|Wutah bathi saben saham ing taun lumaku TFF Pharmaceuticals
